ArticleJournal of experimental & clinical cancer research : CR2019

AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.

Wei-Min Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.